RSCM
ABBV icon

Rail-Splitter Capital Management’s AbbVie ABBV Stock Holding History

Rail-Splitter Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-140,700
Closed -$9.21M – 39
2014
Q4 		$9.21M Buy
+140,700
New +$8.87M 2.81% 22

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rail-Splitter Capital Management's ABBV Position: Q1 2015 in Review

Rail-Splitter Capital Management sold out of AbbVie (ABBV) in Q1 2015, closing a stake of 140,700 shares — an estimated $9.21M sold.

Rail-Splitter Capital Management first reported a position in ABBV in Q4 2014 and held it in 1 quarter. The position peaked at $9.21M in Q4 2014. 1,600 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

  • Rail-Splitter Capital Management reported no remaining AbbVie position as of Q1 2015 after selling out during the quarter.
  • Rail-Splitter Capital Management sold 140,700 AbbVie shares in Q1 2015, an estimated $9.21M.
  • Rail-Splitter Capital Management first reported a position in AbbVie in Q4 2014 and held it in 1 quarter.
  • Rail-Splitter Capital Management's AbbVie position peaked at $9.21M in Q4 2014.
  • 1,600 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Rail-Splitter Capital Management's 13F filing for Q1 2015, filed 27 May 2015.